Free tool
Healthcare stocks
We cover 115 companies in the Healthcare sector. The median market value in the group is $27.39B. Across the group, the median move over the past trading day is −0.22%. 80% of the 114 with a 200-day average trade above it. Price change over the past year runs from −13.2% to +119.6% across the middle 80 percent of the group, with a median of +30.7%.
Other lists in this group
Table
115 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | $1.06T | Mega cap | +62.80% |
| JNJ | Johnson & Johnson | $658.24B | Mega cap | +55.40% |
| ABBV | AbbVie Inc. | $469.68B | Mega cap | +29.36% |
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | +86.85% |
| NVS | Novartis AG | $299.44B | Mega cap | +27.93% |
| AZN | AstraZeneca PLC | $263.12B | Mega cap | +5.09% |
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% |
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% |
| NVO | Novo Nordisk A/S | $208.63B | Mega cap | −13.32% |
| ABT | Abbott Laboratories | $198.74B | Large cap | −11.83% |
| GILD | Gilead Sciences, Inc. | $184.47B | Large cap | +32.51% |
| PFE | Pfizer Inc. | $161.30B | Large cap | +18.72% |
| DHR | Danaher Corporation | $151.40B | Large cap | +5.61% |
| VRTX | Vertex Pharmaceuticals Incorporated | $138.63B | Large cap | +40.66% |
| BMY | Bristol-Myers Squibb Company | $138.03B | Large cap | +47.01% |
| ISRG | Intuitive Surgical, Inc. | $133.22B | Large cap | −21.38% |
| SYK | Stryker Corporation | $126.45B | Large cap | −15.52% |
| MDT | Medtronic plc | $117.78B | Large cap | +2.29% |
| SNY | Sanofi | $108.83B | Large cap | −4.33% |
| MCK | McKesson Corporation | $104.54B | Large cap | +31.57% |
| GSK | GSK plc | $104.29B | Large cap | +32.23% |
| HCA | HCA Healthcare, Inc. | $94.76B | Large cap | +5.96% |
| ELV | Elevance Health, Inc. | $87.30B | Large cap | +32.12% |
| REGN | Regeneron Pharmaceuticals, Inc. | $83.89B | Large cap | +39.36% |
| CI | The Cigna Group | $74.22B | Large cap | −4.84% |
| BSX | Boston Scientific Corporation | $69.81B | Large cap | −54.50% |
| ARGX | argenx SE | $65.51B | Large cap | +47.90% |
| COR | Cencora, Inc. | $62.55B | Large cap | +13.45% |
| MRNA | Moderna, Inc. | $59.75B | Large cap | +496.25% |
| TAK | Takeda Pharmaceutical Company Limited | $58.60B | Large cap | +22.68% |
| CAH | Cardinal Health, Inc. | $55.45B | Large cap | +61.05% |
| EW | Edwards Lifesciences Corporation | $52.32B | Large cap | +12.21% |
| BDX | Becton, Dickinson and Company | $51.81B | Large cap | +25.97% |
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.59% |
| HUM | Humana Inc. | $46.96B | Large cap | +33.14% |
| MDLN | Medline Inc. | $46.53B | Large cap | −13.07% |
| RVMD | Revolution Medicines, Inc. | $46.18B | Large cap | +466.35% |
| HLN | Haleon plc | $44.72B | Large cap | +6.13% |
| TEVA | Teva Pharmaceutical Industries Limited | $44.19B | Large cap | +110.08% |
| A | Agilent Technologies, Inc. | $43.80B | Large cap | +31.46% |
| IDXX | IDEXX Laboratories, Inc. | $43.66B | Large cap | −13.64% |
| IQV | IQVIA Holdings Inc. | $43.04B | Large cap | +38.51% |
| ONC | BeOne Medicines AG | $42.58B | Large cap | +25.21% |
| WAT | Waters Corporation | $40.67B | Large cap | +40.57% |
| VEEV | Veeva Systems Inc. | $39.78B | Large cap | −16.58% |
| RPRX | Royalty Pharma plc | $35.71B | Large cap | +74.00% |
| ALC | Alcon Inc. | $35.13B | Large cap | −10.24% |
| RMD | ResMed Inc. | $34.13B | Large cap | −15.77% |
| ILMN | Illumina, Inc. | $33.95B | Large cap | +125.88% |
| DXCM | DexCom, Inc. | $33.65B | Large cap | +16.47% |
| GEHC | GE HealthCare Technologies Inc. | $33.35B | Large cap | −1.15% |
| BIIB | Biogen Inc. | $32.66B | Large cap | +62.12% |
| CNC | Centene Corporation | $32.34B | Large cap | +127.01% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $32.12B | Large cap | −47.38% |
| ZTS | Zoetis Inc. | $32.03B | Large cap | −49.50% |
| BNTX | BioNTech SE | $28.28B | Large cap | +9.27% |
| MTD | Mettler-Toledo International Inc. | $28.10B | Large cap | +8.81% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +21.14% |
| INSM | Insmed Incorporated | $27.16B | Large cap | −7.54% |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.12% |
| ROIV | Roivant Sciences Ltd. | $26.55B | Large cap | +206.51% |
| PHG | Koninklijke Philips N.V. | $26.38B | Large cap | +1.27% |
| INCY | Incyte Corporation | $25.97B | Large cap | +51.01% |
| WST | West Pharmaceutical Services, Inc. | $24.63B | Large cap | +42.61% |
| STE | STERIS plc | $23.09B | Large cap | −4.41% |
| GH | Guardant Health, Inc. | $22.94B | Large cap | +169.17% |
| THC | Tenet Healthcare Corporation | $21.89B | Large cap | +50.70% |
| GMAB | Genmab A/S | $21.42B | Large cap | +36.20% |
| VTRS | Viatris Inc. | $19.35B | Large cap | +66.19% |
| ZBH | Zimmer Biomet Holdings, Inc. | $19.34B | Large cap | −4.32% |
| MEDP | Medpace Holdings, Inc. | $17.28B | Large cap | +30.74% |
| JAZZ | Jazz Pharmaceuticals plc | $16.89B | Large cap | +100.35% |
| ASND | Ascendis Pharma A/S | $16.41B | Large cap | +29.66% |
| NBIX | Neurocrine Biosciences, Inc. | $15.92B | Large cap | +13.36% |
| SOLV | Solventum Corporation | $15.58B | Large cap | +25.57% |
| BBIO | BridgeBio Pharma, Inc. | $15.52B | Large cap | +60.05% |
| COO | The Cooper Companies, Inc. | $14.25B | Large cap | −1.93% |
| CRL | Charles River Laboratories International, Inc. | $14.09B | Large cap | +81.27% |
| EXEL | Exelixis, Inc. | $14.05B | Large cap | +45.68% |
| RVTY | Revvity, Inc. | $13.93B | Large cap | +42.93% |
| BAX | Baxter International Inc. | $13.70B | Large cap | +8.90% |
| ICLR | ICON Public Limited Company | $13.03B | Large cap | −2.91% |
| CORT | Corcept Therapeutics Incorporated | $12.95B | Large cap | +71.81% |
| PEN | Penumbra, Inc. | $12.72B | Large cap | +21.02% |
| BMRN | BioMarin Pharmaceutical Inc. | $12.70B | Large cap | +11.85% |
| ELAN | Elanco Animal Health Incorporated | $12.53B | Large cap | +35.64% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $12.52B | Large cap | +308.99% |
| FMS | Fresenius Medical Care AG | $12.51B | Large cap | −3.21% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $12.45B | Large cap | +26.78% |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | +46.30% |
| TEM | Tempus AI, Inc. | $12.40B | Large cap | −6.49% |
| SNN | Smith & Nephew plc | $12.23B | Large cap | −19.49% |
| EHC | Encompass Health Corporation | $11.92B | Large cap | −1.75% |
| DVA | DaVita Inc. | $11.41B | Large cap | +30.89% |
| SMMT | Summit Therapeutics Inc. | $11.35B | Large cap | −42.63% |
| TECH | Bio-Techne Corporation | $11.35B | Large cap | +29.33% |
| BTSG | BrightSpring Health Services, Inc. | $11.32B | Large cap | +156.37% |
| ALGN | Align Technology, Inc. | $11.31B | Large cap | +12.09% |
| GMED | Globus Medical, Inc. | $11.16B | Large cap | +35.10% |
| CYTK | Cytokinetics, Incorporated | $11.01B | Large cap | +109.36% |
| AXSM | Axsome Therapeutics, Inc. | $10.85B | Large cap | +69.99% |
| GKOS | Glaukos Corporation | $10.65B | Large cap | +89.83% |
| KRYS | Krystal Biotech, Inc. | $10.65B | Large cap | +143.67% |
| MOH | Molina Healthcare, Inc. | $10.57B | Large cap | +13.35% |
| IONS | Ionis Pharmaceuticals, Inc. | $10.56B | Large cap | +48.21% |
| PRAX | Praxis Precision Medicines, Inc. | $10.54B | Large cap | +704.28% |
| UHS | Universal Health Services, Inc. | $10.53B | Large cap | −1.76% |
| KYMR | Kymera Therapeutics, Inc. | $10.53B | Large cap | +197.09% |
| ENSG | The Ensign Group, Inc. | $10.43B | Large cap | +5.01% |
| BIO | Bio-Rad Laboratories, Inc. | $10.40B | Large cap | +32.71% |
| HSIC | Henry Schein, Inc. | $10.30B | Large cap | +31.02% |
| RGEN | Repligen Corporation | $10.25B | Large cap | +51.67% |
| APGE | Apogee Therapeutics, Inc. | $10.21B | Large cap | +257.11% |
| RDY | Dr. Reddy's Laboratories Limited | $10.18B | Large cap | −14.19% |
| ABVX | ABIVAX Société Anonyme | $10.17B | Large cap | +46.70% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.